Eledon Pharmaceuticals, Inc. Net Fee Amt
Eledon Pharmaceuticals, Inc. (ELDN) had Net Fee Amt of $1.58 thousand as of 2026-09-04, per its S-8 filed 2026-09-04.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-09-04
- 2026-09-04: Net Fee Amt $1.58K.
- 2026-04-28: Net Fee Amt $53.17K.
| Period end | Net Fee Amt |
|---|---|
| 2026-09-04 | $1.58K S-8 · filed 2026-09-04 |
| 2026-04-28 | $53.17K S-3 · filed 2026-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |